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Principles of Fetal Surgery
Ahmed Abdelghaffar Helal
Abstract
Fetal therapy (in utero therapy) is a type of special therapy which aims to 
prevent or correct congenital anomalies in fetus, and prevents their severe con-
sequences on later fetal development. It includes the use of in utero human fetal 
stem cell transplantation, fetal gene therapy and gene-editing technology as a new 
treatment for fetal genetic disorders. It started with open fetal surgery and then sig-
nificantly advancing with innovations, toward minimally invasive fetal procedures, 
which are undoubtedly the future of fetal surgery, with the goal of providing the 
best possible fetal outcome, while minimizing the morbidity and mortality to the 
mother. The goal of fetal treatments is to decrease both fetal and maternal risks and 
prevent premature rupture of membranes. Fetal ultrasound and MRI are crucial for 
successful fetal interventions. Moreover, multidisciplinary fetal teams, including 
fetal surgeon, ultrasonographer, perinatologist, and anesthesiologist, are essential 
for optimum care to both mother and fetus. Finally, any new modality of fetal 
therapy must be thoroughly evaluated in animal models before clinical practice. 
In this chapter, we discuss the basic principles of fetal surgery, milestones of fetal 
surgery, specific fetal anomalies that are amenable for fetal surgery, successful fetal 
surgery criteria and future of fetal surgery.
Keywords: fetal therapy, in utero therapy, fetal team, minimally invasive  
fetal procedures
1. Introduction
Fetal surgery or in utero therapy tries to prevents or corrects multiple congenital 
anomalies in the fetus to prevent their severe consequences on later fetal develop-
ment. It started with open fetal surgery then innovations toward minimally invasive 
procedures have occurred. In this chapter, we discuss the basic principles of fetal 
surgery, the general history of its development, important specific conditions and 
procedures used to treat them, and the future of the field.
2. Key points
• The goal of fetal treatments is to decrease both fetal and maternal risk and 
prevent premature rupture of membranes.
• Real-time ultrasound and fetal MRI is crucial to the implementation and 
success of fetal procedures.
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• Multidisciplinary fetal teams, including a fetal surgeon, ultrasonographer, peri-
natologist, and anesthesiologist, are critical to the delivery of optimum care.
3. History and general principles of fetal surgery
In 1963 first fetal intervention was performed (Table 1), the first fetal transfusion 
was reported by Liley. He used Tuohy needle (size 16-G) into the fetal peritoneal 
space. He injected a contrast material into the amniotic cavity to localize the fetal 
abdomen and the swallowed contrast opacify the fetal bowel. In the 1970s, endos-
copy was used for direct visualization of the fetus, and the first fetal blood sampling 
or biopsy tissue was reported, however because of the limited technical skill, the 
therapeutic uses were not applicable [1, 2]. After that, with more use of ultrasound 
as non-invasive diagnostic tool, the use of diagnostic fetoscopy was replaced with 
percutaneous needle-based techniques under ultrasound guidance. In the 1980s 
open fetal surgery was started (direct exposure of the fetus by maternal laparotomy 
and hysterostomy), then open fetal surgery was replaced with a less invasive fetos-
copy, where video camera was inserted inside the uterus under ultrasound guides. 
At first, fetoscopy was performed in amniotic fluid medium, using a single port to 
enter the uterine cavity and with a side way working channel. However, amniotic 
fluid medium poses many limitations for many fetal surgeries especially that require 
dissection and suture. Low quality images in the fluid medium, and any bleeding will 
prevent an adequate imaging, and it can end the procedure. Moreover, the “fluctua-
tion” of the fetus during the intervention prevent maintenance of the ideal accessible 
position. In 2010 Kohl et al. use low insufflation pressure carbon dioxide of amniotic 
cavity which was left with some amount of amniotic fluid [3–6].
4. Milestones in development of fetal surgery
Criteria for fetal surgery are summarized in Table 2.
4.1 Ethical considerations
The ethical issues in the field of fetal surgery are complex because the medi-
cal intervention is always invasive, often experimental, involves at least two 
patients the mother and fetus, and the success rate is difficult to measure. On the 
First fetal intervention 1963
Direct visualization of the fetus 1970
Start of open fetal surgery 1982
Thoraco-amniotic fetal shunt placement 1987
Treatment of twin–twin transfusion syndrome by laser ablation 1990
Closure of fetal myelomeningocele using fetoscopy 1997
Treatment of fetal congenital diaphragmatic hernia by tracheal clipping (Fetendo technique) 1997
Excision of fetal amniotic band using fetoscopy 1997
Treatment of fetal congenital diaphragmatic hernia by fetoscopic balloon tracheal occlusion 
technique
2001
Table 1. 
Time scales for important fetal surgeries.
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other hand, strong evidence on the benefits of fetal surgery are not present, with 
many centers considered fetal surgery as an experimental technique to correct 
fetal anomalies. Controlled randomized studies to evaluate the effects of fetal 
surgeries on both mother and fetus are still needed. More often, doctors attempt 
fetal surgery in clinical settings without reporting post-operative outcomes in 
medical journals. The overall goal of fetal interventions is clear: to improve the 
health of fetus by intervening before birth to correct or treat prenatally diag-
nosed abnormalities. Mother and fetus that undergo these interventions must 
have the same protection afforded to other study participants, with detailed 
explanation of both short and long-term risks and benefits of these interven-
tions on both the mother and the fetus. Therefore, diagnostic or therapeutic fetal 
intervention, cannot be performed without mother explicit informed consent 
(Table 2) [7–10].
4.2 Surgical techniques and procedures
4.2.1 Surgical team
In fetal surgery, there are complex diseases and two patients, so careful planning 
and open communication before, during, and after surgery between the members 
of the multidisciplinary care team are essential. The team must include pediatric 
surgery, obstetrics, pediatric anesthesia, obstetric anesthesia, cardiology, radiology, 
otolaryngology, neonatology, neonatal nursing, and operative room nursing [11, 12].
During any fetal procedures, the use of ultrasound will guide the pediatric 
surgeon and/or obstetrician and allow for monitor the fetus during surgery. The 
surgeon should actively communicate with the anesthesia team, as well as nursing 
and scrub staff, throughout the procedure. Also, the presence of knowledgeable 
technical support staff familial with the specialized equipment and instrument is 
essential [13, 14].
4.2.2 Surgical approach
Currently, fetal surgery can be classified into three broader areas; open fetal 
surgery, minimally invasive fetal surgery and EXIT procedures. Each procedure is 
subdivided into several subdivisions, in an attempt to treat a wide number of severe 
pathologies that would compromise the fetus. During minimally invasive fetal 
surgeries a small skin incision on the mother’s abdomen was done. The location of 
the placenta, as well as the intrauterine pathology will guide the site of the planned 
incision. 1–2 mm instruments were used to access the fetus are to minimize mater-
nal morbidity. Also, curved instruments may be used to avoid injury to anteriorly 
placed placenta. During fetal access, any present fluid (ascites, pleural effusions, 
I. Prompt diagnosis of the pathology and associated anomalies.
II. Pathophysiology of the disease is documented, and overall prognosis is promising
III. No curative postnatal treatment.
IV. Animal models prove feasibility of the in utero technique, preventing serious effects of the 
pathology.
V. Fetal therapy performed in specialized multi-disciplinary fetal care centers within clear procedure 
with local ethics committee approval and signed informed maternal or parent consent.
Table 2. 
Successful fetal surgery criteria.
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Figure 1. 
Fetoscopic laser ablation of abnormal chorionic vessels for TTTS.
cystic structures, or the bladder) are aspirated or shunted into the amniotic space. 
During fetal cardiac valvuloplasty and radiofrequency ablation for treatment of 
complicated twin gestation, needle-based access is very helpful [15–20].
4.3 Fetoscopic procedures
Usually all patients submitted for a fetoscopic procedure are often pre-medicated 
with a tocolytic agent. Local or regional anesthesia are usually used. The surgery 
can be performed in the surgical theater, labor or delivery unit, or in the ultrasound 
department (depends on gestational age of the fetus). The used instruments, 
particularly, endoscopes have undergone numerous evolution, based on prototypes 
developed in animal models. Fetoscopes diameters are between 1.0 and 2.0 mm. 
Sharp trocars have been developed to accommodate the wide range of diameters used 
for different operations. Operative fetoscopy is a sonoendoscopic enterprise that 
has evolved so that the surgical team can see the ultrasound and fetoscopic images 
simultaneously. Basically, the ultrasound is used to identify an appropriate entry 
point to direct the trocar into the amniotic cavity, avoiding the placenta and the fetus 
as well as maternal organs, such as the bowel and bladder. However, some operators 
have documented the safety, in their hands, of a transplacental approach. Despite 
this experience, most operators still attempt to avoid the placenta. Nowadays, 
fetoscopic technique is indicated when direct visualization of the fetus (more than 
ultrasonography) is needed, as in treatment of cases of twin to twin transfusion syn-
drome, posterior urethral valves, constricting amniotic bands, and tracheal balloon 
occlusion for treatment of congenital diaphragmatic hernia. Fetoscopic procedures 
are performed using 1.2- to 3.0-mm endoscopes. Pictured is a 3 mm 0° endoscope, 
adjustable length, with a 1-mm working channel (Figure 1) [21–29].
4.4 EXIT procedures
EXIT procedures principles is to perform controlled delivery to allow for 
fetal intervention and establishment of airway prior to cord clamping/cutting. 
Indications of EXIT procedures includes severe airway obstruction or likelihood 
of cardiopulmonary insufficiency at birth. Cervical masses, congenital lung 
malformations (CLM), congenital high airway obstruction (CHAOS), pulmo-
nary agenesis, transition to ECMO. It performed under general anesthesia (fetal 
anesthesia, uterine relaxation), with maintenance of placental circulation and 
dorsal supine leftward tilt. Steps includes; Pfannenstiel incision, then customized 
hysterotomy based on placental location, partial delivery of fetus, and placement of 
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monitors, fetal airway establishment during surgical intervention then delivery was 
completed with, transition of the baby to postnatal care, and finally completion of 
cesarean section (Figure 2) [30, 31].
4.4.1 Anesthetic care
Before anesthesia, all physiological changes associated with pregnancy must 
be considered. The effects of pregnancy on mother pulmonary and cardiovascular 
function must be considered. Adequate precautions should be taken to prevent 
hypoxemia and aspiration. The magnesium sulfate used in tocolysis may decreases 
capillary oncotic pressure and increases capillary permeability with increased risk of 
pulmonary edema. Aorto-caval compression must be prevented by using left uterine 
displacement. The doses of anesthetic drugs must be adjusted. Maternal local 
anesthesia can be effectively used for most needle-based and single port fetoscopic 
procedures. When multiple ports or caesarian section could be necessary, regional 
anesthesia; epidural or combined spinal epidural can be added. On the other hand, 
fetal anesthesia is indicated only for endoscopic procedures performed directly on 
the fetus. All fetal anesthetic drugs are typically administered through intramuscu-
lar route and consists of opiates and non-depolarizing muscle relaxants. Atropine 
is usually given to avoid fetal bradycardia. For placental or cord procedures with no 
direct fetal contact, the risk–benefit of fetal anesthesia should be weighed [32–35].
5. Drawbacks of fetal surgery
The drawbacks of fetal surgery, includes bleeding, amniotic fluid leak, chorio-
amnionic separation, chorioamnionitis, premature rupture of membranes, preterm 
labor, preterm birth, and fetal loss. Premature rupture of membranes, preterm 
labor is the most common complication of minimally invasive fetal surgery, with 
high morbidity, including oligohydramnios, chorioamnionitis, and preterm deliv-
ery. However, accurate analysis of the frequency of these complications are difficult 
Figure 2. 
Successful oro-tracheal intubation during the EXIT procedure.
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due to variations in both the assessment of the complication as well as reporting 
methods. Factors increasing the risk during minimally invasive fetal procedures 
include the number of ports and the diameter of the used instruments. A system-
atic review of 1376 minimally invasive fetal procedures for lower urinary tract 
obstruction, and twin reversed arterial perfusion reported that increased diameter 
of the instrument and increased number of ports are major predictors of iatrogenic 
premature rupture of membranes [36–38].
Following open fetal procedure, risk of hysterotomy scar weakness may inter-
rupt both current and future labor. Some cases of uterine scar rupture after open 
fetal procedure was reported, starting from the second trimester, may be caused 
only by the uterine distension (with no uterine contractions) which form signifi-
cant risk to both mother and fetus. Moreover, maternal counseling about the risk of 
delivery complications must be considered. On the other hand, minimally invasive 
fetal procedures do not preclude vaginal delivery. However, long-term follow-up of 
subsequent pregnancies after these procedures is not available, beside the complica-
tions of repeat caesarian section, significant advantage of minimally invasive fetal 
procedures should be considered [39, 40].
6. Certain problems amenable for fetal surgery
Some important indications for fetal interventions are summarized in Table 3.
6.1 Twin gestations
6.1.1 Twin–twin transfusion syndrome (TTTS)
Monochorionic (shared) placenta with A-V, V-V, A-A connections and unbal-
anced flow between two twins
• Donor – low flow, oligohydramnios, high output heart failure, brain 
ischemia, small
• Recipient – fluid overload, polyhydramnios, congestive heart failure, hydrops 
fetalis, large
Prognosis: 80–90% mortality for both if untreated.
Fetal Surgery
• High-volume amnioreduction historically (survival of at least one twin 60%)
• Fetoscopic laser ablation of vascular connections
Offered to Stage II or greater
Selective A-V or nonselective
76% single survivor, 36% dual survivors.
The donor twin usually develops hypovolemia, leading to oliguria and oligohy-
dramnios from reduced renal perfusion, and the recipient twin suffers the conse-
quences of hypervolemia, including polyuria and polyhydramnios. Both twins are 
at risk for significant morbidity [41, 42].
Basic principles for TTTS interventions are to prevent preterm delivery caused 
by polyhydramnios, through removing the excess amniotic fluid surrounding 
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the recipient twin, with improved fetal circulation by decreasing pressure on the 
chorionic plate. In 1990, fetoscopic laser was used to coagulate the crossing super-
ficial blood vessels separating the 2 fetal circulations and destroying the inter-twin 
vessels that cause discordant twin–twin transfusion. Nowadays, laser ablation is the 
preferred treatment for TTTS between 16 and 26 weeks of gestation. The procedure 
is performed through a single uterine access site using a fetoscope and thin laser 
(Table 4) [43–45].
6.1.2 Twin reversed arterial perfusion
One normal twin acts as a “pump” for a cardiac, a cephalic twin via A-A 
anastomoses
Fetal surgery Why to interfere?
I-Surgery on the fetus
Congenital diaphragmatic hernia Avoidance of pulmonary hypoplasia and pulmonary hypertension
Sacrococcygeal teratoma Stop of steal phenomenon, avoid cardiac failure and polyhydramnios
Thoracic space-occupying lesions Avoid pulmonary hypoplasia and cardiac failure
Lower urinary tract obstruction Avoid renal failure and pulmonary hypoplasia
Cardiac malformations Avoid hypoplasia or progressing damage to developing heart
Myelomeningocele Repair of exposed spinal nerves, stop cerebrospinal fluid leakage, 
prevent hydrocephaly and hindbrain herniation
II- Placenta, cord or membranes surgery
Complicated monochorionic 
pregnancies:
Arrest of feto-fetal transfusion and its consequences
Twin–twin transfusion syndrome 
(TTTS)
Avoid preterm delivery
Twin-reversed-arterial-perfusion 
sequence
(TRAP) and other discordant 
anomalies
Avoid damage to co-twin
Twin-anemia polycythaemia 
sequence
In some conditions (TTTS/TRAP) reversal of cardiac failure and 
polyhydramnios
III- Selective intra-uterine growth restriction
Amniotic band syndrome Avoid deformities and functional loss
Chorioangioma Avoid of cardiac failure, hydrops fetoplacental and polyhydramnios
Table 3. 
Some important indications for fetal surgery.
I Presence of Poly and oligohydramnios
II Stage I plus non-visualized bladder in donor twin
III Stage II plus seriously abnormal Doppler (umbilical artery absent or reversed end-diastolic velocity, 
ductus venosus reversed flow, pulsatile umbilical venous flow)
IV Stage III plus evidence of hydrops in either twin
V Fetal death
Table 4. 
Staging of TTTS.
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Normal twin much like donor twin in TTTS with R/O high output heart failure, 
hydrops fetalis, 50% mortality
Fetal Surgery
• Open hysterotomy/delivery
• Fetoscopic ligation
• Bipolar cautery/harmonic scalpel division
• Thermal/laser coagulation
• RFA of acardiac/acephalic cord insertion
6.1.3 Selective fetal reduction
In addition to TTTS, other serious problem that can affect monochorionic twin 
pregnancies, includes severe intrauterine growth restriction, structural anomalies, 
twin anemia polycythemia sequence, and TRAP sequence, or a cardiac twinning. 
In some complicated monochorionic pregnancies, elective fetal reduction is rec-
ommended especially for high risk of hemodynamic compromise or intrauterine 
fetal death, aimed to prevent neurologic injury or demise to the co-twin. Fetal 
intra-cardiac potassium chloride injection is contraindicated in these pregnancies, 
because of risk of transmission between twins and selective termination must be 
performed with interruption of blood flow to the fetus. This interruption usually 
performed through ligation of the umbilical cord, fetoscopic laser coagulation, 
ultrasound-guided and bipolar cord coagulation. Selective fetal reduction was seri-
ously indicated in complicated twin pregnancies what is TRAP sequence. In TRAP 
sequence, one twin is incompatible with life due to absent or rudimentary heart, as 
well as absence of other vital structures, as head (anencephaly). This twin usually 
has no placental blood supply, and it receives its blood supply directly through 
vascular connections from the second normal twin (acts as pump twin). Therefore, 
the normal twin will rapidly develop high-output heart failure, with more than 
50% mortality rate. Selective fetal reduction aims to stop blood flow to incompat-
ible with life twin, and save the life of normal (pump) twin. In the largest review 
from 12 fetal centers from the North American Fetal Therapy Network registry 
data, identified 98 patients who underwent percutaneous radio frequency ablation 
of a cardiac twin. In this series, the overall survival of the normal (pump) twin to 
30 days was 80% [46–50].
6.2 Lower urinary tract obstruction (LUTO)
LUTO can be caused by stenosis of the urethral meatus, valves, urethral atresia, 
ectopic insertion of a ureter or peri-vesical tumors. Bladder shunts are effective 
for urine diversion, restoring amniotic fluid and thereby preventing pulmonary 
hypoplasia. Whether shunting effectively salvages renal function is uncertain. For 
that, prior accurate assessment of renal function is required. The actual anatomical 
cause of LUTO proved to be an important predictor. Posterior urethral valves do 
much better in the long run, while babies with urethral atresias or the Prune Belly 
phenotype do less well. At the moment, the two commonly used techniques, are per-
cutaneous vesico-amniotic shunting, under ultrasound guide, where double pigtail 
stent is inserted, usually combined with amnio-infusion. The second procedure is 
fetal cystoscopy, where fetoscope is inserted into the fetal bladder, to diagnose the 
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source of obstruction and to ablate PUV. The commonly used methods to ablate the 
valve, includes guide wires, hydro-ablation and laser-ablation. The first open clinical 
fetal surgical intervention for a case of lower urinary tract obstruction (LUTO), not 
eligible for shunt placement. Instead, fetal ureterostomies were successfully created. 
There were no maternal complications, but unfortunately the fetus never produced 
any urine. On the other hand, main complications of shunting include; failure to 
insert the catheter, occlusion of the catheter, dislocation, and sometimes fistula 
formation. In order to conclude and evaluate the results of in-utero VAS, and its long-
term outcomes, randomized, controlled trial, “Percutaneous vesico-amniotic shunt-
ing versus conservative management for fetal Lower Urinary Tract Obstruction” 
(PLUTO), was performed in the United Kingdom, Ireland, and the Netherlands from 
2006 to 2012. The study performed on 31 cases (16 submitted to VAS, 15 undergo 
conservative treatment). Study reported that fetal cystoscopy, although it is more 
invasive than VAS, it has the advantage of confirming the diagnosis of PUV, and 
more accurate in selection of patients who will benefit from valve ablation. In other 
multi-centric retrospective study includes 50 cases submitted to fetal cystoscopies 
for treatment of LUTO, 30 fetuses were diagnosed with PUV and were treated 
with laser-ablation. Other 13 fetuses were diagnosed with urethral atresia, 5 fetus 
diagnosed with urethral stenosis, and 2 fetuses diagnosed with trisomy 18 (not 
treated). The results of the 54 fetuses with normal karyotype were, 32.4 weeks mean 
delivery gestational age, and 34.8% overall 2 years’ survival. For PUV patients treated 
with laser-ablation, 53.6% 2 years’ survival. Although 20% (6 of the 30) developed 
recurrence of LUTO symptoms, and further fetal procedure was performed in 10% 
(3 patients). Postnatal ablation of PUV was needed in 10 of the 17 survivors. Normal 
renal function at 2 years of age, was achieved in 75% of infants with PUV (12 of the 
16), which considered more promising than the 29% reported in the PLUTO trial 
with VAS. Reports up to date indicate that, minimally invasive fetal procedure (in 
selected cases of LUTO), can improve the survival when compared to expectant 
treatment. However, studies of long term renal function are less encouraging [51–56].
6.3 Intrauterine myelo-meningocele (IMM)
IMM, or Spina bifida, is defined as failure of complete closure of the neural tube 
with exposure of the spinal canal structures. Lumbar or cervical vertebral levels 
are the most commonly affected sites, however IMM can occur anywhere along the 
spine. Neurologic deficits with motor and somato-sensory abnormalities are the 
most feared complications. In addition, bowel and bladder function may be affected 
due to injury of autonomic nervous system. Moreover, mostly all patients with IMM 
will develop Arnold-Chiari II malformation affecting hindbrain, with non-commu-
nicating hydrocephalus, which requires ventriculo-peritoneal shunting. Although 
mortality of IMM was low in the perinatal period, its long-term neurologic morbid-
ity may be fatal, and up to 30% of patients may die before adulthood [57–60].
6.3.1 IMM repair
At the moment, the compared outcomes of pre-natal versus post-natal repair 
of IMM showed that; although prenatal surgery has an increased risk of preterm 
delivery, pre-natal repair had significantly better outcomes than the post-natal 
repair. Pre-natal repair for IMM decrease the risk of death and subsequent needs 
for shunting (nearly at age of 12 months). Also, pre-natal repair improves scores of 
mental and motor function (at 30 months). However, pre-natal repair was associated 
with an increased risk of preterm delivery and uterine dehiscence at labor. Therefore, 
the potential benefits of pre-natal repair must be balanced against the risks of 
Pediatric Surgery, Flowcharts and Clinical Algorithms
10
prematurity and maternal morbidity [61–65]. In a retrospective review of 54 children 
evaluated for lower extremity neuro-motor function and short-term ambulatory 
function following fetal myelomeningocele closure, they concluded that fetal myelo-
meningocele repair results in better than predicted lower extremity neuro-motor 
function at birth and short-term ambulatory status. However, these children con-
tinue to demonstrate movement incoordination which is characteristic for children 
with Spina-bifida. In retrospective study evaluated the incidence and clinical impli-
cations of the development of cutaneously derived intradural inclusion cysts (ICs) 
following fetal myelomeningocele closure through parental questionnaire. They 
concluded that intradural ICs can develop following fetal myelomeningocele repair. 
ICs long-term complications in these children may include deterioration of bladder 
function, and loss of lower-extremity function after fetal myelomeningocele closure. 
Koh et al. 2006 compared urodynamic findings in patients who underwent pre-natal 
closure of IMM with those of patients who underwent post-natal closure. All pre-
natally treated patients had lower lumbo-sacral lesions on neurological examina-
tion. In comparison, 39% of post-natally treated patients showed lack of sphincter 
activity at newborn examination, with similar findings noted at 1-year evaluation. 
Regarding bladder function, all pre-natally treated patients showed detrusor over-
activity, compared to 38% of post-natally treated patients, up to 1-year evaluation. 
They concluded that fetal closure of IMM is associated with a higher incidence of 
complete denervation of the external urethral sphincter and detrusor over-activity 
compared to post-natal repair. Open fetal IMM closure has been extensively studied 
and its benefits to the fetus have been proven. Minimally invasive fetoscopic repair is 
technically difficult, with high risk of membrane separation and premature rupture 
of membrane, and its benefits to the fetus have not been proved. Therefore, mini-
mally invasive IMM repair still needs further more studies to confirm its validity for 
clinical applications [66–70].
6.4 Congenital diaphragmatic hernia (CDH)
One in 2500 live infant births may be affected with CDH. It consists of abnormal 
defect in the fetal diaphragm, resulting in herniation of all or part of abdominal 
viscera into the thoracic cavity (according to the defect size). Pulmonary hypoplasia 
and pulmonary hypertension, usually present as a result of abnormal development 
of the lungs and pulmonary vasculature, this may cause persistent fetal circulation 
and respiratory failure with increased mortality rate. Despite great improvement in 
its diagnosis and treatment, infant mortality from isolated CDH still about 20–30%. 
Poor prognostic indicators by ultrasonography include low lung-to-head ratio, liver 
herniation into the thoracic cavity, and low total lung volume detected by fetal 
MRI. Initial experimental studies using sheep models demonstrated that prenatal 
repair of the diaphragmatic hernia could reverse the pulmonary hypoplasia caused by 
a surgically created CDH. The first clinical experience in humans likewise involved 
open fetal surgery. High fetal mortality rate is associated with this approach, because 
of umbilical vein kinking during reduction of the herniated liver into the fetal 
abdomen. Therefore, all recent studies consider that minimally invasive methods, 
taking the upper hand for treatment of CDH, as it stimulates lung growth in utero, 
while open fetal repair of the diaphragmatic defect was abandoned from the clinical 
use. Preliminary experimental studies in fetal lambs were promising, demonstrating 
that fetal tracheal occlusion improved fetal lung growth and reducing the severity 
of pulmonary hypoplasia. In cases of severe CDH, postnatal mortality appears to be 
significantly lower with in utero surgical intervention. Studies of fetal endoscopic 
tracheal occlusion (FETO) performed in cases of severe CDH have demonstrated a 
significantly higher survival rate compared with control fetuses that did not undergo 
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FETO. Severe PAH occurred in 47% of fetuses that underwent FETO, but in 89% of 
patients in the prenatal expectant management group (Figure 3) [58, 71, 72].
So, fetal surgeons prefer minimally invasive procedures to avoid large hyster-
otomy and adequately visualize and access the fetal trachea. In 1997 the first fetal 
endoscopic (Fetendo) tracheal clipping, was done in human fetus, where maternal 
laparotomy was done, then 4 trocars was inserted through uterus to access and clip 
the fetal trachea. For the fear of serious complications of tracheal damage and vocal 
cord paralysis during clipping, fetoscopic balloon tracheal occlusion technique 
was introduced, in which no fetal neck dissection and only single uterine port was 
needed. Fetal endoscopic tracheal occlusion (FETO) is usually performed between 
26 and 30 weeks of gestation., A trocar is placed through the maternal abdomen 
into the amniotic cavity guided by ultrasound, and fetoscope is inserted through the 
fetal mouth, then advanced into the fetal trachea. Once the carina has been retched, 
the balloon is inflating with physiologic solution and left just above the carina. 
The correct position is then checked by ultrasound imaging. In some studies, the 
tracheal balloon was removed at the time of delivery through ex utero intrapartum 
therapy. However, balloon removal before birth not only allows for the possibility 
of vaginal birth, but also was shown to increase pneumocyte cells differentiation 
type II, with increasing surfactant production. Currently, tracheal occlusion can be 
reversed in utero, by performing second fetoscopic procedure (typically at 34 weeks 
of gestation) [73, 74]. A multicenter European series including 210 cases of FETO 
with severe CDH (liver up and lung-to-head ratio ≤ 1) they reported 48.0% rate of 
survival to discharge, with 47.1% incidence of premature rupture of membrane. Up 
to date meta-analysis comparing survival outcome between FETO and a contempo-
rary control group, reported that FETO improves survival compared with standard 
perinatal care in fetuses with isolated CDH and severe pulmonary hypoplasia (lung-
to-head ratio ≤ 1). 46.3% of fetuses (Fifty-one of 110) who had undergone FETO 
survived to discharge, compared with 5.9% (6 of 101) in the control group, giving the 
FETO group more significant survival chance. However, the true benefits of FETO 
are difficult to determine because the severity of CDH was not measured uniformly 
and there was great variability in the postnatal care of these infants. International, 
randomized controlled studies to evaluate the role of intrauterine fetal surgery in 
CDH cases with moderate and severe pulmonary hypoplasia is still needed [75].
Figure 3. 
Tracheal occlusion in fetus with congenital diaphragmatic hernia (CDH) to increases lung volume, decreases 
herniation of abdominal viscera, and improves postnatal lung function.
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6.5 Amniotic band syndrome (ABS)
Amniotic band syndrome can lead to fetal death from umbilical cord strangula-
tion and/or congenital limb deformity or loss, presumed to result from ischemia 
caused by constriction bands that interfere with vascular perfusion. There is 
increasing experience with intrauterine release of congenital constrictions and 
evidence is mounting that this therapy may help save/restore some limb function 
and morphology. The location of the bands and timing of fetal damage will affect 
the presentation, severity, and outcome of the condition. For example, pseudosyn-
dactyly or limb amputation can be the results of constriction bands at the extremi-
ties, whereas more midline bands can result in craniofacial, thoracic, or abdominal 
defects, and may be fatal. The etiology of this syndrome is unknown, and theories 
range from a genetic basis or early disruption of the germinal disc to traumatic dis-
ruption of the membranes later in fetal development. Fetoscopic release of amniotic 
bands using minimally invasive surgery, can help in preservation of life and or limb 
saving in cases of ABS. The present acceptable functional outcome in 50% of cases 
is promising, although, clear selection criteria are needed to justify the risk of this 
in-utero invasive procedure, through increased experience and larger studies on this 
type of therapy for ABS (Figure 4).
In cases of extremity involvement by amniotic band syndrome, the band must 
be released using fetoscope to save the normal development of the limb and allow 
for normal limb function. Ultrasound imaging can easily diagnose the problem, 
showing; distal limb edema and interrupted blood flow by Doppler, with or without 
visualization of the constricting band. Although, the available reports include 
small case series, its results suggest that fetuses must have distal arterial limb flow 
detected by Doppler in order to benefit from intervention. Moreover, data from 
recent studies reported that fetuses with single limb involvement tend to do better 
than those with multiple involved limbs. Surprising, the incidence of PROM with 
this procedure seem to be higher than for other fetoscopic procedures, (reported 
rates up to 78%). Although, small number of cases were reported in all available 
studies, and considering the learning curve in this studies, it could also be related to 
inherent membrane problems in these fetuses [76, 77].
6.6 Sacrococcygeal teratoma (SCT)
Although the mortality rate is 5% for SCT diagnosed in the newborn, the 
mortality rate is about 50% for fetal SCT. Rupture of the tumor, or hemorrhage 
inside, or high output heart failure, and premature labor, form the main causes of 
fetal loss. Every attempt at interventions, to prevent this high prenatal mortality are 
the target of study of several fetal centers. Resection of the tumor (in utero) should 
be consider for treatment of pre-mature patients with early signs of heart failure or 
placentomegaly.
• Removal of the external part of the tumor is usually preferred, followed by 
later removal of its pelvic extension.
• Alternatively, radio-frequency, or thermal ablation can be used to occlude 
supplying arteries to the tumor.
It is important to note the related morbidity of all mentioned procedures, like 
risk of preterm delivery, beside procedure failure rate. The related morbidity can 
be reduced with minimally invasive procedures, however, the fear from decreased 
efficacy in local control, still a significant problem. Moreover, these less invasive 
13
Principles of Fetal Surgery
DOI: http://dx.doi.org/10.5772/intechopen.85883
procedures should be used as early as possible, preferably before early signs of 
heart failure, to prevent IUFD. Certainly the best option is complete tumor resec-
tion, if possible. A systematic review on 34 cases of SCT from 1980 to 2013, using 
minimally invasive fetal procedures, they reported 44% (14/32) overall survival 
with 29.7 ± 4.0 weeks, as mean gestational delivery age. They considered heart 
failure as a bad prognostic indicator, (30% survival rate (6/20)). Another review 
compares two minimally invasive procedures, direct tumor control, and vascular 
occlusion of the tumor feeding vessels. Study included 33 cases, 11 cases submitted 
to vascular occlusion (group A) and 22 submitted to direct tumor control (group 
B). They reported 63.6% (7/11) survival in vascular ablation (group A) compared to 
40.9% (9/22) in direct tumor control (group B). They claimed that reduction of the 
tumor blood supply slowly appears safer than rapid tumor necrosis which may lead 
to hemorrhage inside the tumor. Regarding outcomes of fetuses with large SCTs 
and fetal hydrops before viability, due to rarity of the tumor the available small case 
series suggest that fetal intervention does confer a survival advantage. However, 
randomized trials are needed to make a valuable conclusion, also long-term out-
comes data are needed. Because these procedures are associated with significant 
risks, so to get the best benefit these patients must be performed only in specialized 
centers, and must be limited to cases presented with both high-output heart failure 
and fetal hydrops [78].
6.7 Cystic pulmonary airway malformations (CPAM)
Most prenatally detected lung lesions are cystic pulmonary airway malforma-
tions (CPAM), broncho-pulmonar sequestrations or so called ‘hybrid’ lesions, 
containing features of both. The outcome of most lesions are favorable even without 
pre-natal intervention, despite often impressive appearance at mid-gestation. 
During pregnancy many lesions may regress, or disappear completely. Therefore, 
non-operative treatment (watchful waiting) is preferred by most fetal surgeons. 
Surprisingly, pressure effect or hemo-dynamic changes may cause sudden physi-
ologic derangements, which may end with progressive heart failure and intra-
uterine demise. Therefore, pre-natal intervention may be warranted to improve 
outcome. Pre-natal interventions for fetal lung lesions aim to alleviate the pressure 
effect of the mass by partial or complete removal of the lesion. Many surgical and 
non-surgical options have been reported.
• In macrocystic lesions, needle thoraco-centesis or thoraco-amniotic shunt drain-
age under ultrasound guided may be used for decompression.
Figure 4. 
Some amniotic bands may constrict fetal limbs, and may be serious to cause limb amputation.
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• In microcystic lesions, cysts are too small for drainage. In these cases, open fetal 
surgery has been performed.
• When a systemic feeding vessel is found, percutaneous laser coagulation or injec-
tion of a sclerosing agent can be successful.
Routine ultrasound used as screening method for detection of congenital lung 
lesions and require referral to a specialist center. Other co-existing problems of the 
fetus should be carefully evaluated to determine, the magnitude of related compli-
cations, delivery place, time and type, and if intra-uterine intervention is needed. 
Minimally invasive intra-uterine fetal intervention for severe lesions can greatly 
improve the prognosis of these fetuses. In a large study of thoraco-amniotic shunt 
placement for congenital lung mass or pleural effusion, performed on 75 fetuses at 
Children’s Hospital of Philadelphia, they showed 55% decrease in congenital cystic 
adenomatoid malformation volume and 27% of cases showed complete drain-
age of pleural effusion (73% showed partial drainage of effusions) with hydrops 
resolution in 83% of fetuses (43/53), which was greatly correlated with survival. 
Survival to delivery was 93% (70/75), median gestational age was 36 weeks, with 
68% (51/75) long-term survival rate. Fifty-six percent of fetuses were delivered 
at an average of 10 weeks after shunt placement. Duration of stay in the neonatal 
intensive care unit of 21 days, with for greater than 24 hours. This series affirms the 
survival benefit risk patients, but underscores the risks inherent to in utero inten-
sive neonatal therapy required [79, 80].
7. Future of fetal surgery
Minimally invasive treatment is undoubtedly the future of fetal surgery, with 
the goal of providing the best possible outcome for the fetus, while minimizing 
the morbidity or mortality to the mother. So the concept of treating two patients 
at the same time is the challenging goal. To this end, significant efforts are being 
made toward safest methods for fetal intervention, particularly premature rup-
ture of membranes. Currently a collaboration between University of California 
San Francisco, the University of California Berkeley, and Caltech is focusing on 
the development of a biocompatible adhesive (methyldihydroxyphenylalanine-
based polymers) to preseal amniotic membranes before fetal surgery to prevent 
PPROM. This formula is currently under development and called “Amnioseal” 
which can be delivered just below the uterus to preseal the fetal membrane before 
amniotic access. At the moment, prenatal stem cell transplantation and gene 
therapy is under extensive research to treat a wide range of genetic conditions, and 
to extend the current application of fetal surgical intervention for only correction 
of structural fetal anomalies. The in utero stem cell transplantation will prevent 
the process of abnormal immune development before the fetus cellular differentia-
tions. Two types of fetal stem cell therapy are currently under investigations for 
potential clinical use the in utero hematopoietic stem cell transplantation and 
mesenchymal stem cell transplantation. Many recent clinical trials of in utero 
hematopoietic stem cell transplantation reported that it has had a limited success 
in recipients without underlying immunodeficiency, however, some experimental 
data in a large animal model of intrauterine hematopoietic stem cell transplanta-
tion have demonstrated clinically relevant levels of chimerism, may be supporting 
its role for inherited hematologic disorders. On the other hand, the use of in utero 
human fetal mesenchymal stem cell transplantation has been reported for osteo-
genesis imperfect, although the preliminary results are promising, it temporally 
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results. Finally, the studies of fetal gene therapy and gene-editing technology as a 
new treatment lines for fetal genetic disorders, are significantly advancing in the 
field of fetal therapy. However, the safety and long-term effect of these new types 
of treatment must be thoroughly evaluated in animal models before its applica-
tions in clinical practice.
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